Epigenetic and genetic features of 24 colon cancer cell lines

Cell lines are invaluable biomedical research tools, and recent literature has emphasized the importance of genotype authentication and characterization. In the present study, 24 out of 27 cell line identities were confirmed by short tandem repeat profiling. The molecular phenotypes of the 24 colon cancer cell lines were examined, and microsatellite instability (MSI) and CpG island methylator phenotype (CIMP) were determined, using the Bethesda panel mononucleotide repeat loci and two epimarker panels, respectively. Furthermore, the BRAF, KRAS and PIK3CA oncogenes were analyzed for mutations in known hotspots, while the entire coding sequences of the PTEN and TP53 tumor suppressors were investigated. Nine cell lines showed MSI. Thirteen and nine cell lines were found to be CIMP positive, using the Issa panel and the Weisenberger et al. panel, respectively. The latter was found to be superior for CIMP classification of colon cancer cell lines. Seventeen cell lines harbored disrupting TP53 mutations. Altogether, 20/24 cell lines had the mitogen-activated protein kinase pathway activating mutually exclusive KRAS or BRAF mutations. PIK3CA and PTEN mutations leading to hyperactivation of the phosphoinositide 3-kinase/AKT pathway were observed in 13/24 cell lines. Interestingly, in four cell lines there were no mutations in neither BRAF, KRAS, PIK3CA nor in PTEN. In conclusion, this study presents molecular features of a large number of colon cancer cell lines to aid the selection of suitable in vitro models for descriptive and functional research.

[1]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[2]  B. Sordat,et al.  Establishment of a cell line (Co-115) from a human colon carcinoma transplanted into nude mice. , 1976, Cancer research.

[3]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[4]  W. Wolberg,et al.  Establishment and characterization of human colorectal cancer cell lines. , 1984, Cancer research.

[5]  M. Loda,et al.  CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.

[6]  A. Barbat,et al.  Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. , 1988, Cancer research.

[7]  G. Moore,et al.  Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. , 1979, Cancer research.

[8]  I. Arzimanoglou,et al.  Microsatellite instability in human solid tumors , 1998, Cancer.

[9]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[10]  M. Loda,et al.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.

[11]  A. Gazdar,et al.  CHARACTERISTICS OF COLORECTAL CARCINOMA CELL LINES paraffin embedded sections of xenografts , 2006 .

[12]  B. Sordat,et al.  Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.

[13]  K. Kinzler,et al.  Mutations of GTBP in genetically unstable cells. , 1995, Science.

[14]  D. Dexter,et al.  N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. , 1979, Cancer research.

[15]  R. Lothe,et al.  Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas , 2011, Molecular Cancer.

[16]  H. Drexler,et al.  Widespread intraspecies cross‐contamination of human tumor cell lines arising at source , 1999, International journal of cancer.

[17]  D. Christiani,et al.  The p53 codon 72 polymorphism and lung cancer risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  V. Detours,et al.  Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? , 2009, Biochimica et biophysica acta.

[19]  T. Ried,et al.  Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines , 2009, Genes, chromosomes & cancer.

[20]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[21]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[22]  Barry S Taylor,et al.  Genomic and biological characterization of exon 4 KRAS mutations in human cancer. , 2010, Cancer research.

[23]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[24]  D. Dexter,et al.  Heterogeneity of cancer cells from a single human colon carcinoma. , 1981, The American journal of medicine.

[25]  R. Lothe,et al.  Genome signatures of colon carcinoma cell lines. , 2004, Cancer genetics and cytogenetics.

[26]  A. Duval,et al.  Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines , 2001, Oncogene.

[27]  Ying Liu,et al.  Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Lothe,et al.  DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset , 2010, PloS one.

[29]  J. Willson,et al.  Heterogeneity of human colon carcinoma , 2004, Cancer and Metastasis Reviews.

[30]  Nicolai J. Birkbak,et al.  Chromosomal instability confers intrinsic multidrug resistance. , 2011, Cancer research.

[31]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[32]  D. Shibata,et al.  Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation , 1994, Nature Genetics.

[33]  P. A. van den Brandt,et al.  The CpG island methylator phenotype in colorectal cancer: progress and problems. , 2012, Biochimica et biophysica acta.

[34]  D. Dexter,et al.  Chemotherapy of cell‐line‐derived human colon carcinomas in mice immunosuppressed with antithymocyte serum , 1977, Cancer.

[35]  G. Wahl,et al.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.

[36]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[37]  B D Kahan,et al.  Human colonic adenocarcinoma cells , 1976, In Vitro.

[38]  R. Shoemaker.  The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[39]  Jun Zhang,et al.  p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis , 2012, PloS one.

[40]  J. Minna,et al.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science? , 2010, Lung cancer.

[41]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2011 , 2011, Nucleic Acids Res..

[42]  P. Lønning,et al.  The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[44]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[45]  T. Chen,et al.  DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. , 1995, Cancer genetics and cytogenetics.

[46]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[48]  Richard Lugg,et al.  Mutation analysis of 24 known cancer genes in the NCI-60 cell line set , 2006, Molecular Cancer Therapeutics.

[49]  Qinghua Wu,et al.  DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets , 2007, Molecular Cancer.

[50]  J. Hopper,et al.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. , 2011, The Journal of molecular diagnostics : JMD.

[51]  B. Vogelstein,et al.  Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. , 1995, Oncogene.

[52]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[53]  C. Amos,et al.  Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. , 2003, Cancer research.

[54]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[55]  M. Brattain,et al.  Heterogeneity of malignant cells from a human colonic carcinoma. , 1981, Cancer research.

[56]  P. Laird,et al.  Analysis of the Association between CIMP and BRAFV600E in Colorectal Cancer by DNA Methylation Profiling , 2009, PloS one.

[57]  L. Suardet,et al.  Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta 1 and beta 2. , 1992, Cancer research.

[58]  T. Chen,et al.  WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. , 1987, Cancer genetics and cytogenetics.

[59]  B. Dutrillaux,et al.  Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status , 2000, British Journal of Cancer.

[60]  W. Bodmer,et al.  Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel , 2012, Proceedings of the National Academy of Sciences.

[61]  M. Brattain,et al.  Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts. , 1981, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[62]  A. McCullough.  Comprehensive molecular characterization of human colon and rectal cancer , 2013 .

[63]  J. Arends,et al.  Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. , 2002, Gastroenterology.

[64]  M. Rousset,et al.  Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs , 1995 .

[65]  J. Fogh.  Human Tumor Cells in Vitro , 1975, Springer US.

[66]  J. Issa.  CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[67]  Duane A. Compton,et al.  Examining the link between chromosomal instability and aneuploidy in human cells , 2008, The Journal of cell biology.

[68]  P. Laird,et al.  Genome-scale analysis of aberrant DNA methylation in colorectal cancer. , 2012, Genome research.

[69]  Suet Yi Leung,et al.  Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. , 2007, Molecular biology of the cell.

[70]  Martin A. Nowak,et al.  The role of chromosomal instability in tumor initiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  William Arbuthnot Sir Lane,et al.  ATM activates p53 by regulating MDM2 oligomerization and E3 processivity , 2009, The EMBO journal.

[72]  L. Mayo,et al.  The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. , 2002, Trends in biochemical sciences.

[73]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..

[74]  Jonathan M. Mudge,et al.  The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. , 2009, Genome research.